本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 证券代码：600569 证券简称：安阳钢铁 编号：2025—084 安阳钢铁股份有限公司 2025 年上半年主要经营数据公告 本公告经营数据未经审计，请投资者注意投资风险并审慎使用。 特此公告。 安阳钢铁股份有限公司董事会 2025 年 8 月 28 日 主要产品 产量（万吨） 销量（万吨） 销售价格 （元/吨） 板带材 371.94 368.50 3,210.33 其他 61.50 61.31 2,961.98 二、公司 2025 年 1-6 月主要品种产量、销量、销售价格情况 根据上海证券交易所《上海证券交易所上市公司自律监管指引 第 3 号—行业信息披露》要求，公司将 2025 年上半年主要经营数据 公告如下： 一、公司主要财务数据 单位：元 币种：人民币 | 主要会计数据 | 本报告期 | 上年同期 | 本报告期比上年 同期增减(%) | | --- | --- | --- | --- | | | 2025 年 1-6 月 | 2024 年 1-6 月 | | | ...

| 证券代码：605337 | 证券简称：李子园 | 公告编号：2025-062 | | --- | --- | --- | | 转债代码：111014 | 转债简称：李子转债 | | 浙江李子园食品股份有限公司 关于 2025 年半年度主要经营数据的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 浙江李子园食品股份有限公司(以下简称"公司") 根据上海证券交易所《上海 证券交易所上市公司自律监管指引第 3 号——行业信息披露》的有关规定，现将公 司 2025 年半年度的主要经营数据（未经审计）公告如下： 一、主要业务经营情况 (一)主营业务按产品类别分类情况 单位：元 币种：人民币 (三)主营业务按地区分布分类情况 单位：元 币种：人民币 销售模式 2025 年半年度营业收入 2024 年半年度营业收入 同比增长幅度 经销 585,047,720.29 645,252,695.67 -9.33% 直销 33,412,905.04 30,970,662.58 7.89% 合计 618,460,625.33 676,223 ...

| | 主营业务分产品情况 | | | | --- | --- | --- | --- | | | | 营业收入 | | | 分产品 | 2025 年上半年 | 2024 年上半年 | 同比坪 | | 特A+类 | 4, 311, 323, 749. 36 | 4, 654, 451, 094. 94 | -7.3 | | 特A类 | 2, 232, 128, 408. 59 | 2, 215, 742, 971. 50 | 0. 74 | | Ａ 类 | 232, 282, 462. 47 | 258, 215, 471. 52 | -10. C | | B 类 | 76, 798, 387. 46 | 81, 995, 000. 09 | -6. 3. | | C类、D类 | 26, 517, 063. 72 | 43, 742, 057. 16 | -39. 3 | | 其他 | 2, 827, 651. 40 | 3, 136, 701. 80 | -9. 8. | | | 主营业务分地区情况 | | | | 分地区 | | 营业收入 | | | | 2025 年上半年 | 2024 年上半年 | 同 ...

股票代码：600399 股票简称：抚顺特钢 编号：临 2025-037 抚顺特殊钢股份有限公司 2025 年半年度经营数据公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没 有虚假记载、误导性陈述或重大遗漏，并对其内容的真实性、准确性 和完整性承担个别及连带责任。 | 产品名称 | 经营指标 | 2025 年 1-6 | 月 | 2024 年 1-6 月 | 增减情况（%） | | --- | --- | --- | --- | --- | --- | | 合金结构 | 产量（万吨） | 9.67 | | 10.89 | -11.22 | | 钢 | 销量（万吨） | 9.57 | | 11.29 | -15.26 | | | 平均售价（元/吨，不含税） | 10,863.72 | | 13,287.79 | -18.24 | | 工具钢 | 产量（万吨） | 4.54 | | 3.93 | 15.46 | | | 销量（万吨） | 4.58 | | 4.20 | 9.08 | | | 平均售价（元/吨，不含税） | 16,847.88 | | 16,856.84 | -0.05 | | 不锈钢 ...

Company Overview - Zhejiang Gongdong Medical Instrument Co., Ltd. specializes in the research, development, production, and sales of disposable medical consumables [1] - The main products include medical testing, blood collection, sampling, medical care, drug packaging, and others [1] Financial Performance - For Q1 2025, the company reported revenue of 264 million yuan, a year-on-year decrease of 2.74% [1] - The net profit for the same period was 27.41 million yuan, down 39.23% year-on-year [1] - The gross profit margin stood at 32.40% [1] Market Position - As of August 22, the company's stock closed at 20.45 yuan, down 1.06%, with a rolling PE ratio of 29.29 times [1] - The total market capitalization is 4.509 billion yuan [1] - In comparison, the average PE ratio for the medical device industry is 56.95 times, with a median of 40.49 times, placing Gongdong Medical at the 58th position in the industry ranking [1][2] Shareholder Information - As of March 31, 2025, the number of shareholders increased to 8,909, up by 735 from the previous count [1] - The average market value of shares held by each shareholder is 352,800 yuan, with an average holding of 27,600 shares [1]

五新隧装 第一节 重要提示 公司董事、监事、高级管理人员保证本报告所载资料不存在虚假记载、误导性陈述或者重大遗漏，并对 其内容的真实性、准确性和完整性承担个别及连带责任。 公司负责人杨贞柿、主管会计工作负责人杨娟及会计机构负责人（会计主管人员）杨娟保证季度报 告中财务报告的真实、准确、完整。 本季度报告未经会计师事务所审计。 本季度报告涉及未来计划等前瞻性陈述，不构成公司对投资者的实质承诺，投资者及相关人士均应 对此保持足够的风险认识，并且应当理解计划、预测与承诺之间的差异。 事项 是或否 是否存在公司董事、监事、高级管理人员对季度报告内容存在异议或无法保证其真实、 □是 √否 准确、完整 是否存在未出席董事会审议季度报告的董事 □是 √否 是否存在未按要求披露的事项 □是 √否 证券代码 : 835174 湖南五新隧道智能装备股份有限公司 目 录 是否审计 □是 √否 是否被出具非标准审计意见 □是 √否 第二节 公司基本情况 一、 主要财务数据 单位：元 报告期末 上年期末 报告期末比上年 （2025 年 3 月 31 日） （2024 年 12 月 31 日） 期末增减比例% 资产总计 1,084,52 ...

Group 1 - The core viewpoint of the articles highlights the performance and valuation of Gongdong Medical, which closed at 20.96 yuan, up 3.76%, with a rolling PE ratio of 30.02, marking a new low in 33 days, and a total market capitalization of 4.622 billion yuan [1][2] - Gongdong Medical's PE ratio is significantly lower than the industry average of 55.70 and the industry median of 39.08, ranking 58th in the medical device sector [1][2] - As of March 31, 2025, Gongdong Medical had 8,909 shareholders, an increase of 735 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Group 2 - Gongdong Medical specializes in the research, production, and sales of disposable medical consumables, with key products including medical testing, blood collection, collection, medical care, and drug packaging [1] - The latest quarterly report for Q1 2025 shows Gongdong Medical achieved revenue of 264 million yuan, a year-on-year decrease of 2.74%, and a net profit of 27.41 million yuan, down 39.23%, with a gross profit margin of 32.40% [1]

Company Overview - Company name: Zhejiang Gongdong Medical Instrument Co., Ltd. specializes in the research, production, and sales of disposable medical consumables [1] - Main products include medical testing, blood collection, sampling, medical care, drug packaging, and others [1] Financial Performance - As of Q1 2025, the company reported revenue of 264 million yuan, a year-on-year decrease of 2.74% [1] - Net profit for the same period was 27.41 million yuan, down 39.23% year-on-year [1] - The sales gross margin stood at 32.40% [1] Market Position - The company's current stock price is 19.83 yuan, with a PE ratio of 28.40 times [1] - Total market capitalization is 4.372 billion yuan [1] - Compared to the industry average PE of 54.56 times and median PE of 37.54 times, the company ranks 56th in the medical device sector [1][2] Shareholder Information - As of March 31, 2025, the number of shareholders increased to 8,909, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1]

Company Overview - Company name: Zhejiang Gongdong Medical Instrument Co., Ltd. specializes in the research, production, and sales of disposable medical consumables [1] - Main products include medical testing, blood collection, sampling, medical care, drug packaging, and others [1] Financial Performance - As of Q1 2025, the company reported revenue of 264 million yuan, a year-on-year decrease of 2.74% [1] - Net profit for the same period was 27.41 million yuan, down 39.23% year-on-year [1] - The sales gross margin stood at 32.40% [1] Market Position - The company's closing stock price on July 4 was 20.72 yuan, with a PE ratio of 29.68 times [1] - The total market capitalization is 4.569 billion yuan [1] - In comparison, the average PE ratio for the medical device industry is 51.05 times, with a median of 36.62 times, placing Gongdong Medical at the 66th position in the industry [1][2] Institutional Holdings - As of Q1 2025, four institutions hold shares in Gongdong Medical, including two funds, with a total holding of 14.5259 million shares valued at 402 million yuan [1]

证券代码：600569 证券简称：安阳钢铁 编号：2025-037 安阳钢铁股份有限公司 2025 年第一季度主要经营数据公告 安阳钢铁股份有限公司董事会 2025 年 4 月 28 日 主要 产品 产量（万吨） 销量（万吨） 销售价格 （元/吨） 板带材 177.87 170.98 3,265.14 其他 27.90 28.22 3,006.81 二、公司 2025 年 1-3 月主要品种产量、销量、销售价格情况 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 根据《上海证券交易所上市公司自律监管指引第 3 号—行业信息披 露》要求，公司将 2025 年第一季度主要经营数据公告如下： 一、公司主要财务数据 主要会计数据 2025 年 1-3 月 2024 年 1-3 月 本报告期比上年 同期增减(%) 营业收入 7,443,574,570.49 8,507,632,906.16 -12.51 归属于上市公司股东的净利润 18,291,831.47 -483,950,766.71 不适用 归属于上市公司股东的扣除非 经常 ...